Notice Information
Notice Title
ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE
Notice Description
Procurement of Janssen's vaccine candidate Ad26.COV2-S.
Lot Information
Lot 1
This contract has been procured using the negotiated procedure without prior publication under regulation 32 of the Public Contracts Regulations 2015 on the basis that the award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to secure priority access to a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors.
Procurement Information
The award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid 19 pandemic (Regulation 32(2)(c)).
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-029301
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/002970-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651600 - Vaccines
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 12 Feb 20215 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 15 Jan 20215 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- BUSINESS ENERGY AND INDUSTRIAL STRATEGY
- Contact Name
- Not specified
- Contact Email
- vtfcontracts@beis.gov.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SW1H 0ET
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI35 Westminster and City of London
- Delivery Location
- TLE Yorkshire and The Humber
-
- Local Authority
- Westminster
- Electoral Ward
- St James's
- Westminster Constituency
- Cities of London and Westminster
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-029301-2021-02-12T17:45:33Z",
"date": "2021-02-12T17:45:33Z",
"ocid": "ocds-h6vhtk-029301",
"initiationType": "tender",
"tender": {
"id": "4846/01/2021",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33651600",
"description": "Vaccines"
},
"mainProcurementCategory": "goods",
"description": "Procurement of Janssen's vaccine candidate Ad26.COV2-S.",
"lots": [
{
"id": "1",
"description": "This contract has been procured using the negotiated procedure without prior publication under regulation 32 of the Public Contracts Regulations 2015 on the basis that the award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to secure priority access to a viable vaccine to end the Covid-19 pandemic (Regulation 32(2)(c)). Additional information: Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false,
"status": "cancelled"
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "BE"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_EXTREME_URGENCY",
"description": "Extreme urgency brought about by events unforeseeable for the contracting authority/entity and in accordance with the strict conditions stated in the directive"
}
],
"procurementMethodRationale": "The award of the contract to Janssen is strictly necessary for unforeseeable reasons of extreme urgency; i.e. the urgent requirement to find a viable vaccine to end the Covid 19 pandemic (Regulation 32(2)(c))."
},
"awards": [
{
"id": "002970-2021-4846/01/2021-1",
"relatedLots": [
"1"
],
"title": "ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-5607",
"name": "JANSSEN PHARMACEUTICA NV"
}
]
}
],
"parties": [
{
"id": "GB-FTS-5606",
"name": "Business Energy and Industrial Strategy",
"identifier": {
"legalName": "Business Energy and Industrial Strategy"
},
"address": {
"streetAddress": "1 Victoria Street",
"locality": "London",
"region": "UK",
"postalCode": "SW1H0ET",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "VTFContracts@beis.gov.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.gov.uk/government/organisations/department-for-business-energy-and-industrial-strategy",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "01",
"description": "General public services"
}
]
}
},
{
"id": "GB-FTS-5607",
"name": "JANSSEN PHARMACEUTICA NV",
"identifier": {
"legalName": "JANSSEN PHARMACEUTICA NV"
},
"address": {
"streetAddress": "30 Turnhoutseweg",
"locality": "Beerse",
"region": "BE",
"postalCode": "B-2340",
"countryName": "Belgium"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-5608",
"name": "Department of Business, Energy and Industrial Strategy",
"identifier": {
"legalName": "Department of Business, Energy and Industrial Strategy"
},
"address": {
"streetAddress": "1 Victoria Street",
"locality": "London",
"postalCode": "SW1H 0ET",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-5606",
"name": "Business Energy and Industrial Strategy"
},
"contracts": [
{
"id": "002970-2021-4846/01/2021-1",
"awardID": "002970-2021-4846/01/2021-1",
"title": "ADVANCE PURCHASE AGREEMENT FOR SARS-CoV-2/COVID-19 VACCINE",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2021-01-15T00:00:00Z"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"language": "en"
}